CorMedix Inc. CRMD
$5.39
-5.36%
at last close
Market Cap$420.12 million
P/E Ratio—
Div Yield—
Volume3.31M
52-Week Range
$5.34$13.02
Analyst Ratings
- Consensus
- Buy — 7 Buy · 0 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $14.86 (+175.6% upside)
Key Stats
- Today's Range
- $5.34 – $5.75
- 50-Day Range
- $5.34 – $8.74
- 52-Week Range
- $5.34 – $13.02
- Volume
- 3.31 million shs
- Average Volume
- 1.35 million shs
- Market Cap
- $420.12 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 5.13%
- Days to Cover
- 2.46
About CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Related Stocks
Compare head-to-head: CRMD vs LLY·CRMD vs JNJ·CRMD vs ABBV·CRMD vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.